Literature DB >> 21338585

Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis.

David Henrique Rodrigues1, Norinne Lacerda-Queiroz, Aline Silva de Miranda, Caio Tavares Fagundes, Roberta Dayrell de Lima Campos, Rosa Esteves Arantes, Márcia de Carvalho Vilela, Milene Alvarenga Rachid, Mauro Martins Teixeira, Antônio Lúcio Teixeira.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a condition induced in some susceptible species to the study of multiple sclerosis (MS). The platelet activating factor (PAF) is an important mediator of immune responses and seems to be involved in MS. However, the participation of PAF in EAE and MS remains controversial. Thus, in this study, we aimed to evaluate the role of PAF receptor in the pathogenesis of EAE. EAE was induced using an emulsion containing MOG(35-55). EAE-induced PAF receptor knock out (PAFR(-/-)) mice presented milder disease when compared to C57BL/6 wild type (WT) animals. PAFR(-/-) animals had lower inflammatory infiltrates in central nervous system (CNS) tissue when compared to WT mice. However, intravital microscopy in cerebral microvasculature revealed similar levels of rolling and adhering leukocytes in both WT and PAFR(-/-) mice. Interleukine (IL)-17 and chemokines C-C motif legends (CCL)2 and CCL5 were significantly lower in PAFR(-/-) mice when compared to WT mice. Brain infiltrating cluster of differentiation (CD)4(+) leukocytes and IL-17(+) leukocytes was diminished in PAFR(-/-) when compared to WT mice. Taken together, our results suggest that PAF receptor is important in the induction and development of EAE, although it has no influence in rolling and adhesion steps of cell recruitment. The absence of PAF receptor results in milder disease by altering the type of inflammatory mediators and cells that are present in CNS tissue.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338585     DOI: 10.1016/j.brainres.2011.02.036

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

2.  Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.

Authors:  Márcia Carvalho Vilela; Graciela Kunrath Lima; David Henrique Rodrigues; Norinne Lacerda-Queiroz; Vinicius Sousa Pietra Pedroso; Aline Silva de Miranda; Milene Alvarenga Rachid; Erna Geessien Kroon; Marco Antônio Campos; Mauro Martins Teixeira; Antonio Lucio Teixeira
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-19       Impact factor: 4.147

3.  Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis.

Authors:  Matheus Correa-Costa; Vinicius Andrade-Oliveira; Tarcio T Braga; Angela Castoldi; Cristhiane F Aguiar; Clarice S T Origassa; Andrea C D Rodas; Meire I Hiyane; Denise M A C Malheiros; Francisco J O Rios; Sonia Jancar; Niels O S Câmara
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

4.  Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Authors:  Ronald E Cannon; John C Peart; Brian T Hawkins; Christopher R Campos; David S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

5.  Lack of Platelet-Activating Factor Receptor Attenuates Experimental Food Allergy but Not Its Metabolic Alterations regarding Adipokine Levels.

Authors:  Nathália Vieira Batista; Roberta Cristelli Fonseca; Denise Perez; Rafaela Vaz Sousa Pereira; Juliana de Lima Alves; Vanessa Pinho; Ana Maria Caetano Faria; Denise Carmona Cara
Journal:  Biomed Res Int       Date:  2016-05-25       Impact factor: 3.411

6.  Platelet Activating Factor Enhances Synaptic Vesicle Exocytosis Via PKC, Elevated Intracellular Calcium, and Modulation of Synapsin 1 Dynamics and Phosphorylation.

Authors:  Jennetta W Hammond; Shao-Ming Lu; Harris A Gelbard
Journal:  Front Cell Neurosci       Date:  2016-01-08       Impact factor: 5.505

7.  Eomesodermin in CD4+T cells is essential for Ginkgolide K ameliorating disease progression in experimental autoimmune encephalomyelitis.

Authors:  Sheng Chen; Juan Zhang; Wen-Bo Yu; Jing-Cong Zhuang; Wei Xiao; Zhi-Ying Wu; Bao-Guo Xiao
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.